O n Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...

On Tuesday, Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating. Trading at $11.49, ORIC has seen analyst targets ranging from ...

Cantor Fitzgerald notes that the firm discovered ... the high-level news commentary “sounds very positive” for mevrometostat and Oric Pharmaceuticals (ORIC). The firm has an Overweight ...

Cantor Fitzgerald reissued an “overweight” rating on shares of ORIC Pharmaceuticals in a report on Tuesday, January 14th. JPMorgan Chase & Co. increased their price objective on ORIC ...

Wedbush restated an “outperform” rating and set a $20.00 target price on shares of ORIC Pharmaceuticals in a research report on Monday, January 13th. Cantor Fitzgerald reiterated an ...

Cantor Fitzgerald plans to use crypto platforms Anchorage Digital and Copper as part of its Tether-linked Bitcoin financing ...

Cantor Fitzgerald is rolling out its Bitcoin financing business with Anchorage Digital and Copper as custodians.

On Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...

Wall Street asset management firm Cantor Fitzgerald has tapped Copper and Anchorage Digital as custodians for its new bitcoin (BTC) financing business, which aims to provide institutional investors ...